- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01397331
Influence of Anesthesia on Mechanical Efficiency of Left Ventricle in Patients Undergoing Open Heart Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background
From mechanical point of view the goal of the cardiovascular system is to distribute the kinetic energy of blood ejection from the left ventricle (LV) to body organs with minimal loss and greatest efficiency. The left ventricle and the arterial circulation work as "coupled" system. The ideal coupling supposes that a maximum of the energy produced by the LV is converted into forward flow to perfuse the body organs. This matching between "the source" (LV) and "the load" (arterial circulation) is governed by the mechanical properties of these parts of cardiovascular system.
Variety of pathological conditions change this coupling in such a way that may adversely affect the organ blood flow in the presence of unchanged or even high cardiac output, or significantly increase the metabolic demand on the LV for the maintenance of adequate systemic perfusion due to decrease of mechanical efficiency of the work produced by LV.
Although effects of anesthetic agents on myocardial contractility and peripheral vascular tone were extensively studied in clinical conditions, little is known about their influence on ventriculo-arterial coupling. Propofol and inhalational agents appear to impair this equilibrium in animal experiments. This is not surprising, since these agents cause complex dose-dependent changes in many physiologic parameters, including myocardial contractility, left ventricular preload and afterload, diastolic properties of myocardium and baroreceptor control of hemodynamics. Although these properties of anesthetic agents have been delineated extensively, very limited data characterizing their influence on ventriculo-arterial coupling in clinical conditions exist. This information is especially meaningful while planning the anesthetic management of patients undergoing cardiac surgery, where maintenance of circulatory homeostasis is of outmost importance. Since the main hemodynamic goal during anesthesia of the patient with cardiovascular disease is to provide optimal tissue perfusion with minimal myocardial oxygen demand, i.e. with maximal mechanical efficiency, knowledge of anesthetic induced changes in ventriculo-arterial coupling is extremely relevant from the clinical point of view.
The most convenient method for the evaluation of ventriculo-arterial coupling is the analysis of the relationship between LV end-systolic elastance, load-independent measure of myocardial contractility, and effective arterial end-systolic elastance, measure mechanical loading conditions8. Physiological data necessary for the calculation of these parameters may be acquired in relatively non-invasive way by combining and analyzing together recording of arterial blood pressure waveform and data of changes of LV volume, which may be obtained by means of echocardiography.
Objectives
General
The aim of the study is to delineate and compare the changes in ventriculo-arterial coupling caused by two popular anesthetic protocols commonly used in cardiac surgery (intravenous, based on the infusion of propofol, versus inhalational, based on isoflurane) on different stages of the surgery.
Specific
- To compare influence of two anesthetic protocols on myocardial contractility at the end of the surgery.
- To assess net changes in effective arterial elastance produced by surgery with the use of cardiopulmonary bypass and evaluate possible differences between these two anesthetic protocols in respect to changes of arterial tone.
- To evaluate the preservation of ventriculo-arterial coupling by two different anesthetic modes.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Tel Hashomer, Ramat Gan, Israel, 52621
- Department of Anesthesia and Intensive Care, Sheba Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients undergoing elective cardiac surgery
Exclusion Criteria:
- Emergent surgery.
- History of previous cardiac surgery.
- Significant arrhythmias.
- More than trivial valvular disorder.
- Absence of written informed consent.
- Contraindications for transesophageal echocardiography.
- Pregnant women.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Inhalational anesthesia
Group of patients undergoing the surgery under anesthesia based on inhalational anesthetic
|
Anesthesia based on inhalation of 1-1.5 Minimal Alveolar Concentration of Isoflurane with the addition of infusion of remifentanil
|
Active Comparator: TIVA
Group of patients undergoing the surgery under total intravenous anesthesia
|
Anesthesia based on the infusion of 2-5 mg/kg/h of propofol with the addition of infusion of remifentanil
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes of the relationship between left ventricular end-systolic elastance and effective arterial end-systolic elastance.
Time Frame: 15 minutes and 30 minutes after the induction of anesthesia in Inhalational Group and TIVA Group respectively, 15 minutes after the separation from cardiopulmonary bypass, and before the transfer of the patient to the Intensive Care Unit in both groups
|
15 minutes and 30 minutes after the induction of anesthesia in Inhalational Group and TIVA Group respectively, 15 minutes after the separation from cardiopulmonary bypass, and before the transfer of the patient to the Intensive Care Unit in both groups
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in vascular tone and cardiac afterload
Time Frame: 15 minutes and 30 minutes after the induction of anesthesia in Inhalational Group and TIVA Group respectively, 15 minutes after the separation from cardiopulmonary bypass, and before the transfer of the patient to the Intensive Care Unit in both groups
|
arterial end-systolic elastance, left ventricular end-systolic stress
|
15 minutes and 30 minutes after the induction of anesthesia in Inhalational Group and TIVA Group respectively, 15 minutes after the separation from cardiopulmonary bypass, and before the transfer of the patient to the Intensive Care Unit in both groups
|
Changes of measures of global systolic left ventricular function
Time Frame: 15 minutes and 30 minutes after the induction of anesthesia in Inhalational Group and TIVA Group respectively, 15 minutes after the separation from cardiopulmonary bypass, and before the transfer of the patient to the Intensive Care Unit in both groups
|
left ventricular end-systolic elastance, systolic strain and strain rate, myocardial performance index, ejection fraction
|
15 minutes and 30 minutes after the induction of anesthesia in Inhalational Group and TIVA Group respectively, 15 minutes after the separation from cardiopulmonary bypass, and before the transfer of the patient to the Intensive Care Unit in both groups
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sergey Preisman, M.D., Department of Anesthesia and Intensive Care, Sheba Medical Center, Israel 52621
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHEBA-09-7199-SP-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disorder; Heart, Functional, Postoperative, Cardiac Surgery
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingDisorder; Heart, Functional, Postoperative, Cardiac SurgeryCanada
-
Unity Health TorontoCompletedDisorder; Heart, Functional, Postoperative, Cardiac SurgeryCanada, Spain, United States, Israel, Australia, New Zealand, Denmark, Colombia, Egypt, Germany, Singapore, Switzerland, China, Brazil, Greece, India, Malaysia, Romania, South Africa
-
UMC UtrechtZonMw: The Netherlands Organisation for Health Research and DevelopmentTerminatedStroke | Disorder; Heart, Functional, Postoperative, Cardiac Surgery | Cardiac DefectsNetherlands, Hungary
-
University of OxfordCompletedAtrial Fibrillation | Disorder; Heart, Functional, Postoperative, Cardiac Surgery | Ischaemia-reperfusion Injury | Cardiac Insufficiency Following Cardiac SurgeryUnited Kingdom
-
Unity Health TorontoRecruitingCardiac Surgery | Heart | Postoperative | DisorderCanada, Russian Federation
-
Federal University of São PauloUnknownDisorder; Heart, Functional, Postoperative, Cardiac SurgeryBrazil
-
National Taiwan University HospitalUnknownDisorder; Heart, Functional, Postoperative, Cardiac SurgeryTaiwan
-
Fresenius KabiCompleted
-
Nonin Medical, IncCompletedHeart; Dysfunction Postoperative, Cardiac SurgeryUnited States
-
Instituto do CoracaoUnknownC.Surgical Procedure; Cardiac | Heart; Dysfunction Postoperative, Cardiac SurgeryBrazil
Clinical Trials on Isoflurane
-
Konkuk University Medical CenterCompletedIschemic Heart Disease | Valvular Heart DiseaseKorea, Republic of
-
UPECLIN HC FM Botucatu UnespFundação de Amparo à Pesquisa do Estado de São PauloCompletedPatients in Good HealthBrazil
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
UMC UtrechtTerminated
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
Sichuan UniversityCompleted
-
Azienda Ospedaliera Città della Salute e della...CompletedSubarachnoid Hemorrhage | Aneurysmal Subarachnoid HemorrhageItaly
-
University of EdinburghCompletedCardiopulmonary Bypass | Consciousness Monitors | IsofluraneUnited Kingdom
-
University of MichiganUniversity of Pennsylvania; Washington University School of Medicine; James S...Completed
-
Aga Khan UniversityCompleted